Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study - Concepedia

Concepedia

Publication | Closed Access

Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study

58

Citations

19

References

2013

Year

Robert J. van Soest, Ellen S. de Morrée, Liji Shen, Ian F. Tannock, Mario A. Eisenberger, Ronald de Wit

European Urology

Survival BenefitUrologyGenitourinary CancerTax327 StudyMedicineCancer ManagementPredictive MarkerProstatic DiseaseOncologyRadiation OncologyMolecular Oncology

References

	Year	Citations

Page 1